CS
RMTI icon

Credit Suisse’s Rockwell Medical RMTI Stock Holding History

Credit Suisse’s Portfolio RMTI Stock Details RMTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-175
Closed -$19K – 4513
2020
Q4 		$19K Buy
+175
New +$19.6K ﹤0.01% 4306
2019
Q4 		– Sell
-294
Closed -$89K – 4301
2019
Q3 		$89K Buy
294
+2
+0.7% +$615 ﹤0.01% 3982
2019
Q2 		$97K Sell
292
-7
-2% -$3.56K ﹤0.01% 3954
2019
Q1 		$187K Buy
299
+94
+46% +$42.9K ﹤0.01% 3778
2018
Q4 		$51K Buy
205
+43
+27% +$17.1K ﹤0.01% 3800
2018
Q3 		$75K Sell
162
-119
-42% -$57.6K ﹤0.01% 3728
2018
Q2 		$152K Sell
281
-60
-18% -$36K ﹤0.01% 3797
2018
Q1 		$195K Buy
341
+110
+48% +$69.4K ﹤0.01% 3710
2017
Q4 		$147K Sell
231
-276
-54% -$194K ﹤0.01% 3798
2017
Q3 		$478K Buy
507
+228
+82% +$174K ﹤0.01% 3539
2017
Q2 		$242K Buy
279
+10
+4% +$8.19K ﹤0.01% 3560
2017
Q1 		$185K Sell
269
-177
-40% -$117K ﹤0.01% 3635
2016
Q4 		$321K Buy
446
+95
+27% +$65.7K ﹤0.01% 3632
2016
Q3 		$259K Sell
351
-139
-28% -$113K ﹤0.01% 3713
2016
Q2 		$409K Buy
490
+170
+53% +$158K ﹤0.01% 3538
2016
Q1 		$265K Sell
320
-2,274
-88% -$1.79M ﹤0.01% 3572
2015
Q4 		$2.92M Sell
2,594
-2,469
-49% -$2.87M ﹤0.01% 2012
2015
Q3 		$4.29M Sell
5,063
-509
-9% -$738K 0.01% 1669
2015
Q2 		$9.88M Sell
5,572
-2,274
-29% -$2.89M 0.01% 1257
2015
Q1 		$9.43M Buy
7,846
+1,337
+21% +$1.57M 0.01% 1234
2014
Q4 		$7.36M Buy
6,509
+991
+18% +$1.02M 0.01% 1481
2014
Q3 		$5.55M Sell
5,518
-256
-4% -$289K ﹤0.01% 1677
2014
Q2 		$7.62M Buy
5,774
+3,827
+197% +$4.6M 0.01% 1603
2014
Q1 		$2.71M Buy
1,947
+1,423
+272% +$1.85M ﹤0.01% 2284
2013
Q4 		$602K Sell
524
-41
-7% -$56.5K ﹤0.01% 3652
2013
Q3 		$709K Sell
565
-293
-34% -$199K ﹤0.01% 3244
2013
Q2 		$341K Buy
+858
New +$364K ﹤0.01% 3549

Other funds holding RMTI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Credit Suisse's RMTI Position: Q1 2021 in Review

Credit Suisse sold out of Rockwell Medical (RMTI) in Q1 2021, closing a stake of 175 shares — an estimated $19K sold.

Credit Suisse first reported a position in RMTI in Q2 2013 and held it in 27 quarters. The position peaked at $9.88M in Q2 2015. 89 funds tracked by Wall St. Rank hold RMTI as of Q1 2021.

  • Credit Suisse reported no remaining Rockwell Medical position as of Q1 2021 after selling out during the quarter.
  • Credit Suisse sold 175 Rockwell Medical shares in Q1 2021, an estimated $19K.
  • Credit Suisse first reported a position in Rockwell Medical in Q2 2013 and held it in 27 quarters.
  • Credit Suisse's Rockwell Medical position peaked at $9.88M in Q2 2015.
  • 89 funds tracked by Wall St. Rank held Rockwell Medical as of Q1 2021.

Based on Credit Suisse's 13F filing for Q1 2021, filed 14 May 2021.